Tag: Lars Fruergaard Jørgensen

spot_imgspot_img

Analysts evaluate in as the obesity-drug fight warms up

COPENHAGEN, Denmark-- Analysts are paying very close attention to Novo Nordisk and Eli Lilly, as the fight to control the weight reduction...